Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 6,200 shares, a decline of 36.1% from the September 30th total of 9,700 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average daily volume of 14,200 shares, the short-interest ratio is currently 0.4 days.
Alterity Therapeutics Price Performance
Shares of ATHE stock traded down $0.01 during mid-day trading on Monday, hitting $1.16. The stock had a trading volume of 4,900 shares, compared to its average volume of 46,644. Alterity Therapeutics has a 12-month low of $1.01 and a 12-month high of $5.41. The firm’s 50-day moving average is $1.31 and its two-hundred day moving average is $1.68.
Alterity Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Alterity Therapeutics
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Oil Stocks to Watch Before Earnings Come Out
- What is Put Option Volume?
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
- Investing in Commodities: What Are They? How to Invest in Them
- Alphabet’s Earnings Could Surprise—Should You Buy Now?
Receive News & Ratings for Alterity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.